Savara Inc Fair Value Adjustment of Warrants
Savara Inc (SVRA) reported Fair Value Adjustment of Warrants of $26.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2017-05-09
- Savara Inc fair value adjustment of warrants for the quarter ending 2016-12-31 was $0.00.
- Savara Inc fair value adjustment of warrants for the quarter ending 2016-09-30 was $0.00.
- Savara Inc fair value adjustment of warrants for the quarter ending 2016-06-30 was $0.00.
- Savara Inc fair value adjustment of warrants for the quarter ending 2016-03-31 was $26.00K.
- Savara Inc fair value adjustment of warrants for fiscal 2016 was $26.00K, a 93.37% decline from fiscal 2015.
- Savara Inc fair value adjustment of warrants for fiscal 2015 was $392.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 208 month | Fair Value Adjustment of Warrants 211 month | Fair Value Adjustment of Warrants 214 month |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $0.00 derived: sum of 2 quarters · filed 2017-03-06 | $0.00 derived: sum of 3 quarters · filed 2017-03-06 | $26.00K 10-K · filed 2017-03-06 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $26.00K 10-Q · filed 2016-11-08 | $25.00K derived: sum of 4 quarters · filed 2017-05-09 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $26.00K 10-Q · filed 2016-08-09 | $25.00K derived: sum of 3 quarters · filed 2017-05-09 | ||||
| 2016-03-31 | $26.00K 10-Q · filed 2017-05-09 | $25.00K derived: sum of 2 quarters · filed 2017-05-09 | |||||
| 2015-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $392.00K 10-K · filed 2017-03-06 | |||||
| 2015-09-30 | $393.00K 10-Q · filed 2016-11-08 | ||||||
| 2014-03-31 | $12.24M 10-Q · filed 2014-05-05 | ||||||
| 2013-12-31 | $12.24M 10-K · filed 2014-03-26 | ||||||
| 2013-09-30 | $12.24M 10-Q · filed 2013-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |